Hemispheric AI translates brain activity into language: diagnosis of depression and Parkinson in 15 minutes

Israeli startup Hemispheric has just raised $52 million for a technology that looks like a science fiction output: a 15-minute noninvasive brain scan that, with the help of artificial intelligence, translates neuronal activity into language. The system allows physicians to 'hear' the neural patterns of patients and identify biomarkers of conditions such as depression, PTSD and Parkinson.

How does brain AI decode brain signals in language?

The process begins with a state-of-the-art electroencephalography (EEG) equipment that captures the electrical activity of the brain for 15 minutes — no need for surgery or contrast. Crude signals are fed into a trained deep learning model with thousands of tests of patients diagnosed with different conditions. AI learns to map brain wave patterns to specific linguistic structures, generating a 'neural report' that can be read and interpreted by clinicians. According to a report by Haaretz, the company states that the model is able to identify subtle nuances that escape even traditional examinations.

Why is brain AI crucial to mental health?

The great bottleneck in the diagnosis of depression, PTSD and Parkinson's is subjectivity. Today, doctors depend on verbal reports of patients and behavioral scales — which delays interventions and leads to errors. The Hemispheric approach offers an objective metric based on real physiological data. In initial tests, the technology was able to distinguish patients with major depression from healthy controls with accuracy greater than 85%. For Parkinson, early detection may mean years more quality of life with adequate treatment. The startup already plans larger clinical trials in Israel and the United States.

What diseases does brain AI detect: depression, Parkinson's and more?

Hemispheric focused the first studies on three conditions with high prevalence and high social impact: depression (affects more than 280 million people worldwide), post-traumatic stress disorder (PTSD) and Parkinson's disease. Each of them leaves a distinct 'neural signature' in EEG standards — the AI has learned to recognize these signatures and translate them into linguistic descriptions. In the case of PTSD, for example, the model detects hyperactivity in regions related to amygdala and hippocampus, which are converted into textual alerts for the physician. The company also studies expanding to other neurological conditions, such as epilepsy and autism spectrum disorder.

What makes Hemispheric's brain AI unique in the market?

Unlike initiatives such as Neuralink, which require surgical implants, Hemispheric bets on a completely noninvasive method. The 15-minute scan uses high density external sensors, combined with noise removal algorithms and semantic interpretation. The company also developed an interface that presents the results in natural language — a doctor can read sentences as 'standard compatible with major depression, with predominance of theta waves in the frontal region'. This focus on interpretability is a differential for clinical adoption. As a comparison, another recent application of large-scale AI is being used to scroll 100 million Hubble images in search of anomalies, showing how pattern recognition algorithms can revolutionize fields as distinct as astronomy and medicine.

Frequently asked questions about cerebral AI and neurological diagnoses

How does Hemispheric brain scan work?

The patient undergoes a 15-minute noninvasive scan that captures the electrical activity of the brain. The trained AI model interprets these signs and translates them into linguistic patterns that can be associated with specific conditions.

What conditions can be diagnosed?

The technology has shown potential to detect depression, post-traumatic stress disorder (PTSD) and Parkinson, identifying unique neural biomarkers for each condition.

Where is the Hemispheric company based and how much did it raise?

Israeli startup Hemispheric raised $52 million in its latest round and is developing technology in Israel with plans to expand to global markets.